Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
| Format: | Elektroniczne Czasopismo |
|---|---|
| Język: | angielski |
| Wydane: |
MarketLine, a Progressive Digital Media business
|
| Dostęp online: | Full text available on EBSCOhost[Nov 2005-Nov 2005 |
Podobne zapisy
Amgen Case Study: Protecting Epogen from Competition
Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014
Epics, Spectacles, and Blockbusters
od: Neale
od: Neale
Pfizer & AstraZeneca Case Studies: Enhancing Sales Team Tactics
Blockbuster History in the New Russia
od: Norris
od: Norris
Blockbuster, Inc. SWOT Analysis
Pfizer Inc. SWOT Analysis
Pfizer, Inc. - SWOT Analysis
Bristol-Myers Squibb Case Study: Overcoming the threat from generic Antidiabetics
Johnson & Johnson Case Study: Overcoming Genericization in the ADHD Market
Pfizer Case Study: How Celebrex Became Class Leader within a Year of Launch
Pfizer Inc. MarketLine Company Profile
Teva Case Study: Building a Growing Share of the Generics Market
Journal of Competitiveness Studies
On competition.
od: Porter, Michael E.
Wydane: (1998)
od: Porter, Michael E.
Wydane: (1998)
On competition.
od: Porter, Michael E.
Wydane: (1998)
od: Porter, Michael E.
Wydane: (1998)
Drug Safety - Case Reports
From justice to protection : proposal for public health bioethics /
od: Kottow, Miguel
Wydane: (2012)
od: Kottow, Miguel
Wydane: (2012)
Advair Case Study: Effective Promotion of New Drugs
Oust Case Study: Regaining a Competitive Edge in the Home Fragrance Market
Appforge Case Study: Carving a Niche in the Competitive Mobile Software Market
AstraZeneca Case Study: Lifecycle Management of Cancer Drugs
Generics Industry Profile: Australia
Generics Industry Profile: Belgium
Generics Industry Profile: Brazil
Generics Industry Profile: Canada
Generics Industry Profile: China
Generics Industry Profile: Europe
Generics Industry Profile: France
Generics Industry Profile: Germany
Generics Industry Profile: Global
Generics Industry Profile: India